# Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

> **NCT00337493** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 155 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil [CellCept]
- **DRUG:** mycophenolate mofetil [CellCept]
- **DRUG:** Cyclosporine or tacrolimus
- **DRUG:** Cyclosporine or tacrolimus

## Key facts

- **NCT ID:** NCT00337493
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2012-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337493, "Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00337493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*